Literature DB >> 10981043

Treating hypertension: how low is optimal and does aspirin help?

R W Alexander1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10981043     DOI： 10.1007/s11906-999-0074-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  7 in total

1.  How far should blood pressure be lowered? What is the role of the J-curve?

Authors:  L Hansson
Journal:  Am J Hypertens       Date:  1990-09       Impact factor: 2.689

2.  How much should blood pressure be lowered? The problem of the J-shaped curve.

Authors:  A Zanchetti; A Amery; G Berglund; J M Cruickshank; L Hansson; A F Lever; P Sleight
Journal:  J Hypertens Suppl       Date:  1989-12

3.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

Review 4.  Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Authors:  C H Hennekens; J E Buring; P Sandercock; R Collins; R Peto
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

Review 5.  Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective.

Authors:  R W Alexander
Journal:  Hypertension       Date:  1995-02       Impact factor: 10.190

6.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

7.  High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district.

Authors:  L Lindholm; G Ejlertsson; B Scherstén
Journal:  Acta Med Scand       Date:  1984
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.